Posaconazole for Prevention of COVID‐19‐Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: A European Multicentre Case–Control Study (POSACOVID)
Prattes et al., Mycoses, doi:10.1111/myc.70023
https://c19early.org/prattes.html